from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0899/ompA

LFCtreatmentdescriptionclass of inhibitor

-0.131

Amikacinug/mL Amikacintranslation

0.926

Cap5-10ug/mL Capreomycintranslation

1.599

Rox10-50 ug/mL Roxithromycintranslation

-0.252

SM2-5 ug/mL Streptomycintranslation

2.776

Tet5-10 ug/mL Tetracyclinetranslation

1.351

Rif0.2-5ug/mL Rifampicintranscription

0.038

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.230

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.642

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.135

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.223

Clofazimine10-13 ug/mL Clofaziminerespiration

0.075

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.151

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.929

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.671

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.122

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.933

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.052

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.783

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.168

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.233

KCN5-20 ug/mL Potassium cyaniderespiration

0.535

NaN30.2-2 mM Sodium aziderespiration

0.856

Nigericin50 uM Nigericinrespiration

-0.239

TRC10-150 ug/mL Triclosanrespiration

-0.042

TRZ10-25 ug/mL Thioridazinerespiration

0.544

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.331

menadione6-10 ug/mL Menadionerespiration

0.351

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.178

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.621

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.017

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.330

NRP_1Non-replicating persistence stage 1dosRassociated

-0.672

Amp0.2mg/mL AmpicillincellWall

0.270

Cephalexin20-100 ug/mL CephalexincellWall

0.588

Cerulenin0.32-5 ug/mL CerulenincellWall

0.126

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.392

EMB10-20 ug/mL EthambutolcellWall

-0.093

Eta12-40 ug/mL EthionamidecellWall

-0.374

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.855

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.183

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.354

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.499

BZA0.12 mg/mL BenzamidearomaticAmides

0.130

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.320

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.587

H2O24 mM hydrogen peroxideDNAdamaging

0.058

Levo10 ug/mL LevofloxacinDNAdamaging

-0.490

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.768

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.212

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.618

UVUV-irradiationDNAdamaging

0.529

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.251

Antimycin12.5-50 ug/mL Antimycin A?

-0.039

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.126

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.869

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.084

PA8240.2-2 ug/mL PA-824?

-0.038

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.255

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.055

mercaptoethanol2 mM 2-Mercaptoethanol?

0.281

methoxatin10-20 ug/mL Methoxatin?